The University of Otago, Christchurch is one of seven component schools that make up the University of Otago Division of Health Sciences. The University of Otago, Christchurch is based primarily at Christchurch Hospital, in Christchurch Central City, and works in partnership with the Canterbury District Health Board.

During the past decade, University of Otago conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Otago" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Mesoblast, Inc." with 2 trials sponsored, "University of Otago" with 2 trials sponsored, "Brahms AG" with 1 trials sponsored and "DePuy Orthopaedics" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Otago" #1 collaborator was "oVRcome" with 2 trials as a collaborator, "American College of Rheumatology" with 1 trials as a collaborator, "Changi General Hospital" with 1 trials as a collaborator, "Monash University" with 1 trials as a collaborator and "Respivant Sciences Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "University of Otago" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Crohn's Disease" (2 trials), "Heart Failure" (2 trials), "Cardiovascular Diseases" (1 trials) and "Chronic Cough" (1 trials). Many other conditions were trialed in "University of Otago" in a lesser frequency.

Most popular intervention types in "University of Otago" are "Drug" (8 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Bisoprolol" (1 trials), "Cementless Total Knee Arthroplasty" (1 trials) and "Etrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Otago" are 14 trials for "All" genders.

Currently, there are NaN active trials in "University of Otago". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Otago, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Otago, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".